Abcam (ABC) Share Price, News & Analysis

Company Overview

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 6.37 million shs
• Average Volume: 392,791 shs
• Market Capitalization: £2.81 billion
• P/E Ratio: 20,433.33
• Dividend Yield: 0.91%
• Price Target: N/A
• Consensus Rating: N/A

ABC Stock Analysis - Frequently Asked Questions

How do I buy shares of Abcam?

Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Abcam own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Abcam investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG) and Aegean Marine Petroleum Network (ANW).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:ABC
• CIK: N/A
• Web: www.abcam.com
• Phone: +44-1223-696000
• Fax: N/A
• Employees: 1,650
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 20,433.33
• Forward P/E Ratio: N/A
• P/E Growth: 1.57
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 31.60
• Current Ratio: 1.27
• Quick Ratio: 0.89

Sales & Book Value

• Annual Sales: £350.40 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 24.07
• Book Value: GBX 318.30 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 229,272,000
• Free Float: N/A
• Market Cap: £2.81 billion
• Optionable: Not Optionable
• Beta: N/A